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Despite a myriad of technical advances in medical imaging, as well
as the growing need to address the global impact of pulmonary
diseases, such as asthma and chronic obstructive pulmonary disease,
on health and quality of life, it remains challenging to obtain in vivo
regional depiction and quantiﬁcation of themost basic physiological
functions of the lung—gas delivery to the airspaces and gas uptake
by the lung parenchyma andblood—in amanner suitable for routine
application in humans. We report a method based on MRI of hyper-
polarized xenon-129 that permits simultaneous observation of the
3D distributions of ventilation (gas delivery) and gas uptake, as well
as quantiﬁcation of regional gas uptake based on the associated
ventilation. Subjects with lung disease showed variations in gas up-
take that differed from those in ventilation inmany regions, suggest-
ing that gas uptake as measured by this technique reﬂects such
features as underlying pathological alterations of lung tissue or of
local blood ﬂow. Furthermore, the ratio of the signal associatedwith
gas uptake to that associated with ventilation was substantially al-
tered in subjects with lung disease compared with healthy subjects.
This MRI-based method provides a way to quantify relationships
among gas delivery, exchange, and transport, and appears to have
signiﬁcant potential to provide more insight into lung disease.
gas exchange | pulmonary function | pulmonary ventilation
Lung diseases, such as asthma and chronic obstructive pulmonarydisease (COPD), have a tremendous impact on health and
quality of life both in theUnited States andworldwide. For example,
COPD, the fourth-leading cause of death in theUnited States, is the
only major cause of death for which the age-adjusted death rate has
increased in recent years. Progress in understanding the genetic and
molecular pathways involved in such diseases brings a growing need
for improved tools to characterize lung function for such applica-
tions as coupling genetic subtypes to phenotype expression, moni-
toring functional response to new treatments, andaiding in the rapid
development of new respiratory drugs. But despite the many recent
advances in medical-imaging technology, there remains no imaging
approach suitable for routine application in humans that provides
regional depiction andquantiﬁcation of themost basic physiological
functions of the lung: gas delivery to the alveolar airspaces and gas
uptake by the lung parenchyma and blood.
The use of MRI with the hyperpolarized noble gases helium-3
(He3) and xenon-129 (Xe129) has led to the development of
unique strategies for evaluating lung structure and function (1). In
particular, xenon’s relatively high solubility in biological tissues (2),
along with its exquisite sensitivity to its environment that results in
an enormous range of chemical shifts upon solution (3), make
hyperpolarized Xe129 particularly attractive for exploring certain
characteristics of lung function, such as gas exchange and uptake
(4, 5), not accessible with the use of hyperpolarized He3. Upon
inhalation, Xe129 gives rise to multiple MRI spectral peaks in the
lung (6–9), each associated with a physically different compart-
ment. Most Xe129 resides in the lung airspaces (“gas-phase” xe-
non), and is associated with a single large peak, whereas ∼1–2% is
dissolved in the lung parenchyma and blood (“dissolved-phase”
xenon) and gives rise to two or more smaller peaks at chemical
shifts of about 200 ppm from the gas peak (6–9). The small pool of
dissolved-phase xenon exists in dynamic equilibrium with xenon in
the airspaces; driven by diffusion, atoms in the gas and dissolved
compartments continually exchange. The quantitative character-
istics of the process of gas exchange and uptake are determined by
parameters of physiological relevance, such as the thickness of the
blood–gas barrier (5); thus, measurements that quantify this pro-
cess potentially offer a wealth of information on the functional
status of the healthy and diseased lung.
Images that directly depict the dissolved-phase compartments
are required to take full advantage of the information offered by
dissolved-phase Xe129MRI. Although detection of the dissolved-
phase signal in the human lung was demonstrated in early studies,
the associated signal-to-noise ratios were insufﬁcient to permit
acquisition of dissolved-phase images (8). Such imageswere subse-
quently acquired in animals using repeated inhalations of hyper-
polarized Xe129 (5, 10, 11), but with current technology, a multi-
ple-inhalation approach is not feasible in humans. However, with
improvements in gas-polarization hardware (12), liter quantities of
hyperpolarized Xe129 can be obtained with sufﬁcient polarization
to make direct dissolved-phase imaging in humans feasible during
a single breath-hold period. Recently, Cleveland et al. (13) pro-
duced breath-hold images of the dissolved phase in humans fol-
lowing inhalation of 1 L of Xe129. Nonetheless, because the
absolute dissolved-phase signal intensity has no physical meaning,
measurement of the dissolved-phase signal alone cannot make the
critical distinction between pathological alterations in ventilation
(gas delivery to the airspaces) versus those in tissuemicrostructure
or blood ﬂow. Thus, there is a need for an imaging approach
suitable for application in humans that permits quantiﬁcation of
the dissolved-phase signal and, ideally, also permits regional as-
sessment of both ventilation and gas uptake from a single, short
acquisition that can be easily tolerated by subjects with compro-
mised respiratory function due to disease.
The large difference in chemical shift, and hence resonant
frequency, between gas-phase and dissolved-phase Xe129 pro-
vides an opportunity to capture both components in the same
image, thus potentially yielding from a single breath-hold ac-
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quisition simultaneous depiction of the 3D distributions of the gas
after inhalation and of the fraction of gas exchanging into the lung
parenchyma and blood. Simultaneous acquisition of a ventilation
image with matched spatial resolution provides the ideal basis for
normalizing the dissolved-phase signals, allowing regional quanti-
ﬁcation of gas uptake by calculating the ratio of the dissolved-phase
and gas-phase signals. This ratio parameter, which is likely to be
sensitive to pathological changes in lung function, may offer insight
into thephysiological effects of suchdiseases as asthmaandCOPD.
Here we demonstrate the feasibility of such a method for simul-
taneous MRI of ventilation distribution and gas uptake, and pres-
ent preliminary results from healthy and diseased human lung.
Results
Simultaneous MRI of Ventilation Distribution and Gas Uptake. We
developed an MRI acquisition method (pulse sequence) to gen-
erate MRI images that show, side-by-side, Xe129 in the lung air-
spaces and Xe129 dissolved in the lung parenchyma and blood
(Fig. 1). The method was based on an established approach
(radiofrequency-spoiled gradient-echo imaging) for rapid MRI,
allowing completion of a 2D acquisition of the lung in a few sec-
onds and a 3D acquisition in less than 20 s. Because the amount of
Xe129 in the dissolved-phase compartments is much less than that
in the airspaces, and because Xe129 in the airspaces acts as a res-
ervoir for the dissolved-phase compartments, we designed an ex-
citation radiofrequency pulse for the pulse sequence that resulted
in a relatively high degree of excitation (i.e., a high “ﬂip angle”) for
Xe129 in the dissolved-phase compartments, but a relatively
low degree of excitation for Xe129 in the airspaces (Fig. 1B). We
chose sampling characteristics for the pulse sequence (Materials
and Methods) that provided complete separation of the gas and
dissolved components along one of the axes (speciﬁcally, the
“frequency-encoding direction”) of the image (Fig. 1C).
Subject Characteristics and Tolerance of Imaging Procedures. We
enrolled 11 human subjects for simultaneous MRI of ventilation
distribution and gas uptake, including 6 healthy subjects, 3 subjects
with clinically diagnosed asthma, and 2 subjects with clinically di-
agnosed smoking-related COPD (Table 1). Immediately before
MRI, we measured standard lung functional indices based on spi-
rometry, including forced vital capacity (FVC) and absolute and
percent-predicted forced expiratory volume in 1 s (FEV1). Spiro-
metric indices were in the normal range (FEV1 ≥ 80% predicted
and FEV1/FVC ≥ 70%) for the healthy subjects, but below the
normal range for the subjects with lung disease (Table 1).
All subjects were able to inhale the hyperpolarized Xe129 gas
and hold their breath for the required time, which ranged be-
tween 2 s and 18 s. We performed a total of 20 simultaneous gas-
phase, dissolved-phase Xe129 acquisitions in the 11 subjects; we
imaged one of the healthy subjects in two separate sessions
(Table S1). For each subject, we acquired 2D projection images
(i.e., spatially resolved in two directions and integrated over the
thickness of the lung in the remaining direction), 3D images (i.e.,
spatially resolved in all three directions), or both (Table 1). The
xenon inhalations were well tolerated by all subjects, although
6 of the 11 subjects experienced mild transient central nervous
system side effects, such as slight tingling or lightheadedness, with
one or more of the xenon inhalations.
Ventilation Distribution and Gas Uptake in Healthy Subjects. As
expected, the 2D projection acquisitions demonstrated a spatially
uniform distribution of gas-phase Xe129 signal, indicating uniform
ventilation of the airspaces, as well as a spatially uniform distribu-
tion of dissolved-phase Xe129 signal, indicating uniform uptake of
hyperpolarized xenon by the lung tissue and blood (Fig. 1D, subject
1). The 3D acquisitions in healthy subjects also demonstrated
generally uniform distributions of gas-phase and dissolved-phase
signal intensities throughout the lung volume (Fig. 2, top panel of
the central six images from a coronal 3D acquisition in subject 8;
Fig. S1, central eight images from an axial 3D acquisition in subject
9). Nonetheless, in healthy subjects, the dissolved-phase signal in-
tensity was noticeably higher in the posterior portion of the lung
than in the anterior portion (Fig. 2, Top).
We made an incidental ﬁnding of a 1-cm pulmonary nodule in
the upper left lung of one of the healthy subjects (subject 3).
Multiplanar image reconstructions (Fig. 3, A–C) from a 3D ac-
quisition in this subject illustrated the correspondence between
a ventilation defect (i.e., a region of absent signal) in the gas-
phase Xe129 component and a focal region of elevated dis-
solved-phase signal intensity. A coronal proton MRI image (Fig.
3D) at the location of the focal high signal intensity in the dis-
solved-phase component revealed a well-circumscribed nodule in
Fig. 1. Relationships between the spectral peaks of Xe129 and the excita-
tion and frequency-encoding characteristics of an appropriately designed
MRI pulse sequence illustrate how to take advantage of the large chemical
shift difference between gas-phase and dissolved-phase Xe129 to simulta-
neously acquire images of ventilation distribution (gas phase) and gas up-
take (dissolved phase). (A) Representative spectrum of Xe129 in a healthy
human lung showing peaks at 0, 198, and 218 ppm, corresponding to Xe129
in the lung airspaces, dissolved in lung parenchyma and blood plasma, and
bound to hemoglobin in red blood cells, respectively. (B) For simultaneous
imaging of the gas and dissolved components of Xe129, the center fre-
quency of the radio-frequency pulse is chosen so that the main lobe of the
frequency response covers the two dissolved peaks, and the pulse duration is
chosen so that the central region of a side lobe corresponds to the gas-phase
peak (Inset). (C) Dissolved-phase and gas-phase components are separated
along the frequency-encoding direction of the image for appropriately se-
lected pulse-sequence parameter values. (D) A representative coronal 2D
projection image of the healthy lung (subject 1) demonstrates simultaneous
depiction of uniform distributions of ventilation following inhalation and
gas uptake.
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the lung. This subject had participated in several previous research
MRI studies. A retrospective examination of these studies
revealed that the nodule had been absent in October 2008 but
present in January 2009.During the intervening period, the subject
had traveled to Central America as part of a medical mission.
Although a number of colleagues on this trip developed symp-
tomatic respiratory infections, our subject reported no respiratory
symptoms; however, the rapid development of this nodule suggests
an inﬂammatory/infectious etiology, possibly an incidental sub-
clinical pulmonary infection acquired during the trip. A sub-
sequent tuberculin skin test was negative. We hypothesize that
inﬂammation associated with the nodule was responsible for focal
accumulation of dissolved-phase Xe129 and hence the region of
high signal intensity in the dissolved-phase component. Of note,
this subject had otherwise homogeneous gas-phase and dissolved-
phase images, similar to those for the other healthy subjects.
Ventilation Distribution and Gas Uptake in Subjects with Lung
Disease. In the ﬁve subjects with lung disease, both the gas-phase
and dissolved-phase components demonstrated nonuniform signal
distributions. Although the gas distribution modulates the amount
of Xe129 available for exchange, the signal intensity variations in
the dissolved-phase components of the images were similar to but,
importantly, not identical to those in the corresponding gas-phase
components [Fig. 2, Top (subject 8, healthy) versusMiddle (subject
7, asthma) and Bottom (subject 10, mild COPD), with identical
acquisition parameters used for the three subjects].
We found numerous ventilation defects in the gas-phase Xe129
component of the images for the subjects with lung disease, for
example, a ventilation defect in the gas-phase component for
subject 7 (asthma) that had an associated defect in the dissolved-
phase component (Fig. 2,Middle, arrowheads). The bright band of
signal seen just below this defect in the dissolved-phase component
was not present in the gas-phase component, however.
Table 1. Demographic information, spirometry, and types of MRI acquisition for each subject
Experiment no. Subject no.
Subject data
Age, y Sex
FEV1, %
predicted FEV1/FVC, % Health status MRI acquisition type
1 1 21 F 90 80 Healthy 2D projection
2 2 67 M 36 49 Asthma 2D projection
3 3 21 F 104 80 Healthy 3D
4 3 21 F 108 82 Healthy 2D projection, 3D
5 4 63 F 80 66 COPD 2D projection
6 5 25 F 84 88 Healthy 2D projection
7 6 19 F 56 67 Asthma 2D projection
8 7 48 F 68 60 Asthma 2D projection, 3D
9 8 19 F 112 84 Healthy 3D
10 9 20 F 96 81 Healthy 3D
11 10 54 F 81 66 COPD 3D
12 11 19 F 104 84 Healthy 3D
Fig. 2. 3D coronal acquisitions of the whole lung in subject 8 (healthy),
subject 7 (asthma), and subject 10 (mild COPD) show marked spatial varia-
tions in ventilation and gas uptake in the subjects with asthma or COPD
compared with generally uniform distributions in the healthy subject. Each
panel shows the central six 20-mm-thick Xe129 images from the respective
acquisition. For the subject with asthma, arrowheads indicate signal dropout
at the location of a ventilation defect; a band of elevated signal is seen just
below this defect in the dissolved-phase component. For the subject with
mild COPD, arrows indicate regions of elevated signal intensity in the dis-
solved-phase component. MRI pulse-sequence parameters for all acquisitions
include repetition time (TR), 50 ms; echo time (TE), 2.8 ms; ﬂip angle at
dissolved phase, 20°; bandwidth, 110 Hz/pixel (6.2 ppm/pixel); and spatial
resolution, 12 × 12 × 20 mm.
Fig. 3. Dissolved-phase Xe129 accumulated in the pulmonary nodule that
was incidentally found in subject 3 (healthy). (A–C) Coronal (A), sagittal (B),
and axial (C) reconstructions from a 3D acquisition highlighting the corre-
spondence between the focal region of elevated dissolved-phase signal in-
tensity in the upper left lung and a ventilation defect (arrows). (D) Coronal
proton MRI image showing a 1-cm pulmonary nodule (curved arrow) at the
same location. MRI pulse-sequence parameters for the 3D acquisition in-
cluded TR, 35 ms; TE, 2.8 ms; ﬂip angle at dissolved phase, 16°; bandwidth,
110 Hz/pixel (6.2 ppm/pixel); and spatial resolution, 12 × 12 × 12 mm.
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In subject 10 (mild COPD), the signal intensity of the
dissolved-phase component in the anterior portion of the lung
(Fig. 2, Bottom, ﬁrst two images) was clearly higher than that for
the corresponding gas-phase component, whereas the signal
intensities for the gas-phase and dissolved-phase components
were similar in the anterior portion of the lung in the healthy
subjects (e.g., Fig. 2, Top, ﬁrst two images). Further, the dissolved-
phase component in subject 10 showed pronounced variations in
signal intensity that were not matched by variations of the same
magnitude in the gas-phase component (Fig. 2, Bottom, arrows).
Ratio of Dissolved-Phase to Gas-Phase Xe129.Wecalculated the ratio
of the signal intensities for dissolved-phase Xe129 to the signal
intensities for gas-phase Xe129 in the four subjects in whom 3D
acquisitions were performed using identical acquisition parame-
ters. From these results, we calculated themean values for the ratio
on a slice-by-slice basis (Fig. 4). These data correspond to the
images for subjects 7, 8, and 10 (Fig. 2), as well as those for subject
11 (healthy); the volume of gas inhaled was 0.74 L for subjects 7, 8,
and 10 and 1.47 L for subject 11. In the two healthy subjects, the
ratio increased monotonically from the anterior portion to the
posterior portion of the lung (Fig. 4). Healthy subject 11 had
markedly higher ratios in the most posterior slices compared with
healthy subject 8 despite having inhaled a larger volume of gas
(Discussion); thismight be attributable to the two subjects’differing
total lung volumes or differing relative degrees of lung inﬂation at
the start of inhalation. The anterior-posterior variation in the ratio
is consistent with the analogous change noted above in the dis-
solved-phase signal intensity along the anterior-posterior direction
in healthy subjects. For subject 7 (asthma), the ratio in the anterior
portion of the lungwas similar to that in thehealthy subjects, but the
increase in the ratio from anterior to posterior was much smaller
than that in the healthy subjects. In contrast, in subject 10 (mild
COPD), the ratio in the anterior portion of the lung was markedly
elevated compared with that in the healthy subjects and subject
7 and tended to slightly decrease, rather than increase, along the
anterior-posterior direction.
Discussion
We have demonstrated the feasibility of using MRI of hyper-
polarized Xe129 to acquire images in a single short breath-hold
period lasting less than 20 s that simultaneously depict ventilation
distribution and gas uptake in the human lung withmatched spatial
resolution. The distributions of both ventilation and gas uptake
were overall spatially uniform in healthy subjects, as expected.
Nonetheless, 3D acquisitions revealed a gradient in dissolved-
phase signal intensity along the anterior-posterior direction, con-
sistent with the observation of Cleveland et al. (13) and likely due
to the well-described gravity-dependent gradient in lung tissue
density from anterior to posterior in the supine position. Subjects
with lung disease showed spatial variations in ventilation, as
expected based on published studies using hyperpolarized He3
MRI (14–17), as well as in gas uptake, although the variations in
gas uptake differed from the variations in ventilation in many
regions of the lung. This suggests that the gas uptake component as
measured by this technique is not simply a mirror of the amount of
gas present in the local volume, but likely reﬂects other features as
well, such as underlying pathological alterations of lung tissue or
regional blood ﬂow. The preliminary studies presented here are
clearly insufﬁcient to address such issues as the extent to which
variations in perfusion might manifest as measureable changes in
the dissolved-phase signal intensity, but they nonetheless point to
a substantial potential for investigating lung function and disease
using this technique.
The data on the ratio of dissolved-phase to gas-phase Xe129
provide additional support for the potential of this technique. The
effect of gravity on the supine lung has been detected previously in
healthy subjects using hyperpolarized He3 diffusion imaging as
a decrease in apparent diffusion coefﬁcient from the anterior to
posterior portion of the lung. However, the change in the ap-
parent diffusion coefﬁcient was≈30% (18), whereas the change in
the ratio of dissolved-phase to gas-phase Xe129 along the ante-
rior-posterior direction in healthy subjects was roughly 100%
(Fig. 4). More important, however, are the intriguing variations in
the dissolved-phase to gas-phase ratio shown in Fig. 4 for two
subjects with lung disease. These differ markedly from those seen
in the healthy subjects, presumably due to structural or functional
lung changes resulting from disease. It is important to note,
however, that values for the ratio of dissolved-phase to gas-phase
Xe129 and the associated anterior-posterior gradient depend on
the degree of lung inﬂation. Speciﬁcally, the ratios in the middle
and posterior sections of the lung should decrease as lung in-
ﬂation increases, causing the anterior-posterior gradient to de-
crease as well. Thus, if the lungs of a subject with disease were
somewhat hyperexpanded at baseline, then the resulting gradient
would be expected to be lower than that of a healthy subject per-
forming an equivalent breathing maneuver. Regardless, a possible
difference in the degree of lung inﬂation between subject 10 (mild
COPD) and the healthy subjects does not explain the elevated ratio
values seen in the anterior portion of the lung in subject 10 (Fig. 4).
In general, performing future experiments using an MRI-compati-
ble spirometer to permit better control over the degree of lung in-
ﬂation may be valuable.
The decoupling of ventilation and dissolved-phase signals for
certain circumstances is further highlighted by the results in the
healthy volunteer who had an incidental ﬁnding of a small pul-
monary nodule, which appeared as a very bright focus in the
dissolved-phase component of the MRI images. Clearly, hyper-
polarized Xe129, transported through the vasculature, was con-
centrated in the region of the nodule over the course of the
breath-hold acquisition. The signal contribution from Xe129 in
the blood that has traveled to a location distant from the air-
spaces, such as to a solid lesion or the major vessels and heart,
should depend on the frequency and amplitude of radiofrequency
excitation (6, 9, 10). Thus, by selecting appropriate acquisition
parameters, it should be possible to highlight Xe129 that has just
dissolved in tissue versus Xe129 that has been transported away
from the airspaces. Furthermore, the chemical shift difference
between Xe129 in lung tissue and that in red blood cells is sufﬁ-
ciently large (∼20 ppm in humans) to permit selective suppression
or excitation of one of these signal sources using established
strategies, thereby providing another means to tease out the rel-
ative contributions of the different compartments that compose
the dissolved-phase signal.
Fig. 4. Variation in the mean ratio of dissolved-phase to gas-phase Xe129
with slice position differed greatly between subjects with lung disease and
healthy subjects. Mean ratios were calculated from the central six images of
3D acquisitions of the whole lung in subjects 8 and 11 (healthy), subject 7
(asthma), and subject 10 (mild COPD). In the healthy subjects, the ratio in-
creased substantially along the anterior-posterior direction.
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The chemical shift difference between Xe129 in tissue and that
in red blood cells is expected to provide another mechanism for
exploring the relative contributions of these compartments. It is
well known in clinical MRI that a chemical shift difference be-
tween two components leads to oscillatory signal decay as a func-
tion of echo time for image voxels containing a mixture of the
components. The relative contributions of the components can be
assessed by collecting gradient-echo images wherein the echo time
is chosen to correspond to one of the periodic times when the
complex signals are aligned in the same direction (“in-phase”) or in
opposite directions (“opposed-phase”). For the studies presented
here, we chose an echo time approximately equal to the ﬁrst in-
phase time for Xe129 in tissue and red blood cells.
Although 2D projection acquisitions provided images with rel-
atively high signal-to-noise ratios, spatial encoding in the third di-
mension is highly desirable for investigating lung function and
disease, which are inherently spatially heterogeneous. The 3D
acquisitions demonstrated that the acquisition of multiple image
sections within the lung is feasible; however, these images had
relatively low resolution compared with routine clinical images
from proton-based MRI. Nonetheless, several avenues exist for
substantially improving the Xe129 images using our technique.
Ongoing efforts suggest that gas polarizations approximately
double those achieved in our studies can be expected in the near
future (12). Such a polarization—and hence signal—improvement
could be traded for increased spatial resolution. Furthermore, we
expect that optimization of the frequency and amplitude of radio-
frequency excitation will be important for maximizing dissolved-
phase signal levels. Finally, 3D acquisitions are ideally suited for
a compressed-sensing approach (19).As recently demonstrated for
other MRI applications (19, 20), compressed sensing is well suited
for both accelerating the acquisition, which would provide more
ﬂexibility in the selection of timing parameters to highlight selected
compartments, and improving the signal-to-noise ratio due to the
inherent denoising properties of the reconstruction.
As indicated by Eq. [1] (Materials and Methods), spatial reso-
lution and receiver bandwidth are inherently linked. As a result,
decreasing the voxel size (increasing spatial resolution) requires
decreasing the bandwidth as well, which in turn increases chem-
ical shift displacement between the red blood cell and tissue
components along the frequency-encoding direction, and also
increases sensitivity to main ﬁeld inhomogeneity. Strategies for
overcoming this limitation are under evaluation. Another limi-
tation of the current implementation is that the ﬂip angles for the
gas-phase and dissolved-phase components are directly coupled;
changing the ﬂip-angle value for the gas phase relative to that for
the dissolved phase requires redesign of the radiofrequency pulse
waveform. An improved approach would be to independently
design the excitation characteristics for the gas-phase and dis-
solved-phase frequency ranges.
Chemical shift imaging (10, 21) is another MRI acquisition
method that can provide gas-phase and dissolved-phase images.
Chemical shift acquisitions demonstrated in rats using hyper-
polarized Xe129 required many breaths of gas over a period of
several minutes to yield 2D projection images (10), although
chemical shift images have been demonstrated in rabbits using
single breath-hold techniques (22). Chemical shift imaging has the
advantage of yielding data from which images for each resonance
can be estimated; however, for typical image sizes, the method
requires at least an order of magnitude increase in the number of
radiofrequency excitations, which fundamentally limits ﬂexibility in
choosing measurement parameters, especially for 3D acquisitions.
However, by combining spatial and spectral encodingusing anecho-
planar readout (23), chemical shift imaging acquisition can be ac-
celerated signiﬁcantly. Although implementing the original form of
this method for dissolved-phase hyperpolarized Xe129 would be
challenging because of the relatively short T2* MRI values, opti-
mized versions using least squares decomposition (24), which sub-
stantially reduces the required number of echoes, might have
potential for application to hyperpolarized Xe129 lung imaging.
In conclusion, we have demonstrated an imaging method for the
human lung that permits both simultaneous observation of the 3D
distributions of ventilation and gas uptake and quantiﬁcation of
regional gas uptake in a single short acquisition that can be easily
tolerated by subjects with lung disease. This method provides op-
portunities for quantifying relationships among gas delivery, ex-
change, and transport and appears to have signiﬁcant potential to
broaden our understanding of lung disease. Our results, although
obtained from a small number of subjects, suggest differences in
the spatial variations in gas uptake and ventilation in subjects with
asthma and COPD. We speculate that this discordance is due to
regional alterations in tissue status (COPD) or blood ﬂow (COPD
and asthma) that are unrelated to local ventilation, and suggest
that improved understanding of alterations in regional gas uptake
may provide fresh insights into the relative incongruity in some
subjects between subjective symptoms and the results of current
primary tests for assessing the severity of lung disease, such
as spirometry.
Materials and Methods
Acquisition Parameters to Separate Gas-Phase and Dissolved-Phase Xe129. To
achieve the desired separation in the image between the gas and dissolved
components along the frequency-encoding direction, the chemical shift dif-
ference (ΔfG−LP) between Xe129 in the airspaces and Xe129 dissolved in the
lung parenchyma must exceed the frequency bandwidth of the lung (Δflung)
(Fig. 1C). The chemical shift difference, ΔfG−LP, expressed in Hz is γ B0 ΔχG−LP,
where γ is the gyromagnetic ratio for Xe129 (in MHz/T), B0 is the static mag-
netic ﬁeld strength (in T), and ΔχG−LP is the chemical shift difference (in ppm).
On a typical clinical MRI unit, the receiver bandwidth can be directly speciﬁed
and the spatial resolution (i.e., pixel dimensions) can be speciﬁed via the ﬁeld-
of-view and matrix size. In these terms, the frequency bandwidth of the lung
can be expressed in Hz as BWWL/Δx, where BW is the receiver bandwidth
(in Hz/pixel),WL is thewidth of the lung (in mm), andΔx is the pixel dimension
along the frequency-encoding direction (in mm). Assuming that a desired
value for Δx is selected, the requirement for the receiver bandwidth is
BW <
γ B0 ΔχG–LP Δx
WL
: [1]
For example, at 1.5 T and a value of 10mm forΔx, and assuming that the lung
is 240 mm wide, the receiver bandwidth must be <146 Hz/pixel, which is
within the range of values typically used for clinical MRI.
The double outline of the lung for the dissolved-phase component in Fig.
1C illustrates that the signal from the red blood cell compartment should
appear slightly shifted relative to that from the lung parenchyma com-
partment, due to the chemical shift difference between the corresponding
resonances. Nonetheless, this shift may not be appreciated in the image if
the spatial resolution is relatively low, or if the signal from one compartment
is much larger than that from the other compartment.
Human Subjects. All experiments were performed under a physician’s In-
vestigational New Drug application for imaging with hyperpolarized Xe129
using a protocol approved by the University of Virginia’s Institutional Review
Board. The details of the study procedure, including associated risks and
beneﬁts, were explained to each subject, and written informed consent was
obtained before enrollment in the study. Spirometry was performed im-
mediately before MRI using a hand-held device (Koko; PDS Ferraris). Twelve-
lead electrocardiography (HP Pagewriter Xli) was performed immediately
before and immediately after MRI. Throughout the MRI session, the subject’s
heart rate and oxygen saturation level were recorded (3150 MRI Patient
Monitor; Invivo Research), and the subject was monitored for central ner-
vous system side effects of the inhaled xenon. All studies were supervised by
a physician.
MRI Measurements. MRI was performed on a 1.5-T whole-body commercial
scanner (Magnetom Avanto; Siemens) that included the multinuclear im-
aging option and a ﬂexible chest radiofrequency coil (Clinical MR Solutions)
tuned to the Xe129 resonant frequency. Using the scheme outlined in Fig. 1,
a simultaneous gas-phase–dissolved-phase imaging technique was imple-
mented based on a standard radiofrequency-spoiled gradient-echo pulse
sequence. Considering that the signal evolutions depend on the repetition
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time and ﬂip angles, and that the signal amplitudes may decrease markedly
during the course of the acquisition as the hyperpolarized magnetization is
depleted (13), sequential, rather than centric, phase-encoding order was
used, to reduce associated image blurring. The desired response for the
excitation radiofrequency pulse (Fig. 1B) was obtained by systematically
adjusting the timing parameters for a truncated-sinc waveform and then
evaluating the resulting response as predicted by the Bloch equations. The
MRI acquisition parameters are listed in Table S1. Acquisition (breath-hold)
times were between 2 and 18 s.
Enriched xenon gas (87% Xe129) was polarized by collisional spin ex-
change with an optically pumped rubidium vapor using a prototype com-
mercial system (Xemed) that provided gas polarization of≈30%. Immediately
before imaging, 0.1–1 L of hyperpolarized Xe129 gas was dispensed into
a Tedlar bag (Jensen Inert Products) and connected to one arm of a plastic
Y connector. A second Tedlar bag containing a mixture of room air and
medical-grade oxygen was connected to the other arm of the Y connector.
The volumes and relative fractions of room air and oxygen were selected so
that the gas mixture inhaled through the base of the Y connector contained
21% oxygen.
Each subject was positioned supine on the scanner table with the Xe129
radiofrequency coil around the chest; imaging typically began within 10 min
of positioning. Using conventional protonMRI and a breath-hold acquisition,
“scout” images were obtained for positioning of the Xe129 acquisitions.
Next, the subject inhaled a gas mixture containing ≈0.1 L of hyperpolarized
Xe129 from maximum expiration, and a breath-hold acquisition was per-
formed for scanner calibration. Finally, for each of the breath-hold imaging
acquisitions, the subject inhaled a gas mixture containing either 0.5 L of
hyperpolarized Xe129 and 0.24 L of an air–oxygen mixture (subjects 1–10) or
1 L of hyperpolarized Xe129 and 0.47 L of an air–oxygen mixture (subject
11), from maximum expiration.
Ratio of Dissolved-Phase to Gas-Phase Xe129. In four subjects in whom 3D
acquisitions were performed using identical parameters (subjects 7, 8, 10, and
11), the ratio of the signal intensities for dissolved-phase Xe129 to those for
gas-phase Xe129 was calculated. The approximate shift along the frequency-
encoding direction for the dissolved-phase component relative to the gas-
phase component is indicated by the associated chemical shift difference. The
exact shift used for ratio calculations was determined for each subject by
performing a cross-correlation between the dissolved-phase and gas-phase
components of a representative image. Background noise was masked from
the images using an intensity threshold. The ratio was calculated on a pixel-
by-pixel basis for each slice in each image set, and the mean ratio value was
determined for each slice.
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